EUVIMEDEUVIMED entdecken
Crossref

Antiproliferative Activity of the New Analogues of Acridine/Acridone With Oligopeptide Derivatives and Molecular Docking With EGFR and Src Kinase

Monika Gensicka-Kowalewska iD, Krystyna Dzierzbicka, Maria Skrzypkowska, Mateusz Daśko, Piotr Trzonkowski iD

Journal of Peptide Science · 2026

DOI: 10.1002/psc.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Peptide Science, 2026. Verfasst von Monika Gensicka-Kowalewska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Gdansk University of Technology, Gdansk, Poland. Hauptthemen laut MEDLINE: Acridines, ErbB Receptors, Molecular Docking Simulation, src-Family Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Science Center (Poland).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of our work was to analyze new functionalized analogues of 1‐nitroacridine/4‐methyl‐1‐nitroacridine and 4‐nitroacridone connected to tuftsin/retro‐tuftsin derivatives as a potential anticancer therapeutics. Using the MTT assay, we have evaluated the cytotoxic activity of synthesized analogues against the Jurkat cell line and healthy donor–isolated peripheral blood mononuclear cells (PBMCs). Jurkat cells were susceptible to several of the acridine derivatives, whereas PBMCs were sensitive to two compounds only. 4‐Methyl‐1‐nitro‐acridine analogue, classified as compound 28 , has exhibited the greatest anticancer potential with 4‐fold higher cytotoxicity toward Jurkat cells and 12‐fold lower cytotoxicity against PBMCs when compared with control therapeutics. Subsequent molecular docking analysis suggested that binding to epidermal growth factor receptor (EGFR) and proto‐oncogene tyrosine‐protein kinase Src molecules could be, at least partially, responsible for observed biological effects of created acridine/acridone analogues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcridinesErbB ReceptorsMolecular Docking Simulationsrc-Family KinasesAcridonesAntineoplastic AgentsOligopeptidesHumansCell ProliferationProto-Oncogene MasJurkat CellsLeukocytes, MononuclearStructure-Activity Relationship

Stichwörter der Autor:innen

EGFRSrcacridineacridoneanticancer agentsretro‐tuftsin

Substanzen

AcridinesErbB Receptorssrc-Family KinasesAcridonesMAS1 protein, humanProto-Oncogene MasAntineoplastic AgentsOligopeptidesEGFR protein, humanacridone

Autor:innen und Institutionen

  • Department of Organic Chemistry, Gdansk University of Technology, Gdansk, Poland.
  • Department of Medical Immunology, Medical University of Gdansk, Gdansk, Poland.
  • Department of Inorganic Chemistry, Gdansk University of Technology, Gdansk, Poland.

ORCID-Profile: Monika Gensicka-Kowalewska, Piotr Trzonkowski

Förderung

  • National Science Center (Poland)

Zitieren

APA

Gensicka-Kowalewska, M., Dzierzbicka, K., Skrzypkowska, M., Daśko, M., & Trzonkowski, P. (2026). Antiproliferative Activity of the New Analogues of Acridine/Acridone With Oligopeptide Derivatives and Molecular Docking With EGFR and Src Kinase. Journal of Peptide Science. https://doi.org/10.1002/psc.70070

Vancouver

Gensicka-Kowalewska M, Dzierzbicka K, Skrzypkowska M, Daśko M, Trzonkowski P. Antiproliferative Activity of the New Analogues of Acridine/Acridone With Oligopeptide Derivatives and Molecular Docking With EGFR and Src Kinase. Journal of Peptide Science. 2026. doi:10.1002/psc.70070

BibTeX
@article{GensickaKowalewska2026,
  author = {Gensicka-Kowalewska, Monika and Dzierzbicka, Krystyna and Skrzypkowska, Maria and Daśko, Mateusz and Trzonkowski, Piotr},
  title = {Antiproliferative Activity of the New Analogues of Acridine/Acridone With Oligopeptide Derivatives and Molecular Docking With EGFR and Src Kinase},
  journal = {Journal of Peptide Science},
  year = {2026},
  doi = {10.1002/psc.70070}
}
Kostenlos starten →